Trials / Not Yet Recruiting
Not Yet RecruitingNCT06068439
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
A Phase III Multi-center Randomized Placebo-controlled Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic
- Status
- Not Yet Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 355 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of low-dose aspirin (50 mg/day) in renal and cardiac function protection in people with diabetic nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylsalicylic Acid | aspirin 50 mg/d to be taken after dinner (in nonfasting conditions) |
| DRUG | Placebo | Placebo 50 mg/d to be taken after dinner (in nonfasting conditions) |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2027-01-30
- Completion
- 2027-06-30
- First posted
- 2023-10-05
- Last updated
- 2023-10-05
Source: ClinicalTrials.gov record NCT06068439. Inclusion in this directory is not an endorsement.